» Articles » PMID: 14649311

A Different Molecular Pattern of Beta-thalassemia Mutations in Northeast Brazil

Overview
Journal Hemoglobin
Publisher Informa Healthcare
Specialty Hematology
Date 2003 Dec 3
PMID 14649311
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The main hereditary hemoglobin (Hb) disorders of clinical significance in Brazil are sickle cell disease and beta-thalassemia (thal). The sickle gene was introduced by the slave trade, whereas beta-thal was introduced later, due to a massive immigration (mostly by Italians) between 1870 and 1953, mainly to the southeast region of Brazil. Molecular studies performed in the southeast of the country showed a marked prevalence of the nonsense mutation at codon 39 (C --> T) (47-54%), leading to severe forms of beta0-thal. However, the northeast region of the country has a different demographic history, characterized by the absence of the massive Italian immigration. Owing to this and since the majority of cases of beta-thal in Pernambuco, a state located in the northeast of the country, have mild or intermediate clinical and laboratory features, we would predict a different spectrum of beta-thal mutations in this region. We examined 60 unrelated patients (86 beta-thal chromosomes) under regular clinical follow-up in Pernambuco: 6 were regularly transfused beta-thal major subjects, 20 had beta-thal intermedia, 20 had Hb S/beta-thal and 14 were beta-thal trait individuals. The following mutations were found: IVS-I-6 (T --> C) 62.8%, IVS-I-1 (G -->A) 15.1%, IVS-I-5 (G --> C) 9.3%, IVS-I-110 (G --> A) 8.2%, codon 39 (C --> T) 3.5%, and codon 30 (AGG --> AGC) 1.1%. These data show different patterns of beta-thal mutations in two regions of Brazil, demonstrating a thus far unrevealed heterogeneity of the disease in the country.

Citing Articles

Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes.

Figueira C, Guida J, Surita F, Antolini-Tavares A, Saad S, Costa F Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S189-S196.

PMID: 38494406 PMC: 11670601. DOI: 10.1016/j.htct.2024.02.013.


Clinical, laboratory, and molecular characteristics of a cohort of children with hemoglobinopathy S/beta-thalassemia.

Oliveira E, Rolim Belisario A, Silva N, Rezende P, Muniz M, Oliveira L Hematol Transfus Cell Ther. 2024; 46(2):167-175.

PMID: 38182466 PMC: 11150486. DOI: 10.1016/j.htct.2023.11.002.


Association of FOXO3 polymorphism (rs3800231) and clinical subphenotypes of beta thalassemic individuals.

Torres F, Bernardo V, Silva D, Okumura J, Bonini-Domingos C Hematol Transfus Cell Ther. 2020; 44(2):156-162.

PMID: 33309469 PMC: 9123579. DOI: 10.1016/j.htct.2020.09.147.


Hb S/-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Belisario A, Carneiro-Proietti A, Sabino E, Araujo A, Loureiro P, Maximo C Hemoglobin. 2020; 44(1):1-9.

PMID: 32172616 PMC: 7225056. DOI: 10.1080/03630269.2020.1731530.


Use of an automated pyrosequencing technique for confirmation of sickle cell disease.

de Martino C, Alencar C, Loureiro P, Barbara de Freitas Carneiro-Proietti A, Maximo C, Mota R PLoS One. 2019; 14(12):e0216020.

PMID: 31830127 PMC: 6907837. DOI: 10.1371/journal.pone.0216020.